Aurobindo Pharma secures FTC approval for a $250 million acquisition of Lannett Company, enhancing its U.S. manufacturing capabilities.

Aurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic move, expected to conclude by June…

Aurobindo Pharma’s US subsidiary receives US FTC approval to acquire Lannett Company for $250 million, strengthening its position in non-opioid controlled substances and domestic…